InvestSMART

Echo IQ Limited (ASX:EIQ)

ALERT: Price-sensitive ASX Announcement for EIQ
Current share price for EIQ : $1.260 0.02 (1.61%)+
Release
25 Jun 2026 8:51AM
Price at Release
$1.240
Full Release
download
Summary
Echo IQ Limited has signed a binding Heads of Agreement (HOA) with Pro Medicus Limited for a strategic investment and commercial partnership. The agreement outlines an initial investment of A$10 million by Pro Medicus, with an option for an additional A$10 million contingent on FDA clearance of Echo IQ's EchoSolv HF algorithm. This deal aims to enhance Echo IQ's balance sheet, accelerate US market entry, and leverage Pro Medicus's extensive healthcare network. The partnership is expected to validate Echo IQ's AI cardiovascular diagnostic technology and expand its adoption across the US healthcare market.
Key Points
  • Binding Heads of Agreement with Pro Medicus Limited.
  • Initial A$10 million investment with a further A$10 million option.
  • Investment contingent on FDA clearance of EchoSolv HF.
  • Pro Medicus to potentially become a reseller in the US.
  • Partnership enhances Echo IQ's balance sheet and US market opportunities.
  • Strategic alignment focuses on AI-powered cardiac diagnostics.
  • Pro Medicus is a global leader in medical imaging software.
  • Potential strategic validation of Echo IQ’s technology.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.